TNN [7 May 2018]

“คนไทยเฮ!สธ.วิจัยยาต้านไวรัสตับอักเสบCสำเร็จ” – “Thai people! The Ministry of Health announces successful antiretroviral therapy for hepatitis C

Click here to read the article

Thai PBS [7 May 2018]

“กรมควบคุมโรค วิจัยยาต้านไวรัสตับอักเสบซีสำเร็จ” – “Department of Disease Control announces successful research on an antiviral drug for hepatitis C”

Click here to read the article

Matichon Online [7 May 2018]

“คร.ร่วมหลายหน่วยงานชูความสำเร็จโครงการวิจัยยารักษาผู้ป่วยไวรัสตับอักเสบซี” – “Many organizations join in the success of the drug research program to treat patients with hepatitis C”

Click here to read the article

MGR Online [7 May 2018]

“วิจัยพบยาคู่ใหม่ ‘โซฟอสบูเวียร์+เรวิดาสเวียร์’ รักษา ‘ตับอักเสบซี’ หายขาด 96-100%” – “New drug discovery ‘sofosbuvir + ravidasvir’ treatment ‘hepatitis C’ cured 96-100%”

Click here to read the article

22nd International AIDS Conference

23-27 July 2018
Amsterdam, the Netherlands
Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – poster presentation about a paediatric HIV study
DNDi – posters on TB/HIV co-treatment and on the use of oral lopinavir/ritonavir pellets in Kenya

Gigazine [14 April 2018]

“高価な「C型肝炎治療薬」の効果を保ったまま安価で提供するための取り組みが進行中” – “Efforts to provide low cost while maintaining efficacy of ‘expensive hepatitis C treatment’ is ongoing”

Click here to read the article

Drug approved in Argentina for treatment of Chagas disease in children

Buenos Aires, Argentina – 13 April 2018
Argentina has approved the paediatric indication of a drug used for treatment of Chagas disease, benznidazole, which will now be available in 12.5 mg pills, the dose required to treat children under the age of 2. The indication was approved by the Argentinian National Administration for Drugs, Food, and Medical Technologies (ANMAT).